Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Berger

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Breast Cancer Research : BCR|April 29, 2015
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersKaroline B Kuchenbaecker, Susan L Neuhausen, Mark Robson, et al.
Breast Cancer Research : BCR|May 1, 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Claire Bardel, Vincent Danjean, et al.
Plos Genetics|April 5, 2014
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L Milne, Karoline Kuchenbaecker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Breast Cancer Research : BCR|April 29, 2015
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersKaroline B Kuchenbaecker, Susan L Neuhausen, Mark Robson, et al.
Breast Cancer Research : BCR|May 1, 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Claire Bardel, Vincent Danjean, et al.
Plos Genetics|April 5, 2014
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L Milne, Karoline Kuchenbaecker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 9